Koers Proto Script Pharmaceutical Corp. Other OTC
Aandelen
PSCR
US74373V1052
Bedrijfsondersteunende diensten
Omzet 2015 | 881K 820K | Omzet 2016 | 789K 734K | Marktkapitalisatie | 311 mln. 289 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2015 | - 0 | Nettowinst (verlies) 2016 | -7 mln. -6,51 mln. | EV/omzet 2015 * | - |
Nettoschuld 2015 | 27,07K 25,19K | Nettoschuld 2016 | 47,78K 44,47K | EV/omzet 2016 | 394 x |
K/w-verhouding 2015 * |
-
| K/w-verhouding 2016 |
-41,4
x | Werknemers | - |
Dividendrendement 2015 * |
-
| Dividendrendement 2016 |
-
| Vrij verhandelbaar | 89,82% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michelle Rico
CEO | Chief Executive Officer | 56 | 29-06-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michelle Rico
CEO | Chief Executive Officer | 56 | 29-06-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,87% | 70,43 mld. | |
+6,14% | 17,32 mld. | |
+14,28% | 13,86 mld. | |
+10,80% | 12,84 mld. | |
+11,68% | 9,65 mld. | |
-18,93% | 6,57 mld. | |
-8,38% | 5,77 mld. | |
+1,96% | 5,16 mld. | |
+1,91% | 5,07 mld. |